Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$3.38 - $4.22 $40,222 - $50,218
11,900 New
11,900 $43,000
Q4 2018

Feb 13, 2019

SELL
$4.89 - $7.16 $82,983 - $121,505
-16,970 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$6.89 - $7.78 $116,923 - $132,026
16,970 New
16,970 $122,000
Q1 2018

May 15, 2018

SELL
$3.56 - $5.74 $64,080 - $103,320
-18,000 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$2.76 - $3.95 $49,679 - $71,100
18,000
18,000 $61,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $331M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.